116303 ⎘
Hydrolases acting on ester bonds (3.1); Phosphoric monoester hydrolases (3.1.3) Phosphoprotein phosphatase (3.1.3.16), i.e. calcineurin
Drug-Resistant Immune Cells and Methods of Use Thereof
#2ACTIVE LOADING OF CARGO ENTITY INTO LIPID BILAYER PARTICLES USING DIMERIZATION DOMAINS
#3SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF
#4RNAi TARGETING PPP2R5D MISSENSE MUTATIONS FOR TREATMENT OF JORDAN’S SYNDROME
#5TREATMENT OF SPINAL CORD INJURY WITH PTEN INHIBITOR
#6INDUCIBLE SIGNALLING PROTEIN
#7IMMUNOSUPPRESSANT DRUG RESISTANT ARMORED TCR T CELLS FOR IMMUNE-THERAPY OF ORGAN TRANSPLANT PATIENTS
#8Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof
#9ARTIFICIAL EUKARYOTIC EXPRESSION SYSTEM WITH ENHANCED PERFORMANCES
#10Cell
#11Pharmaceutical composition for diagnosing, preventing or treating liver cancer using SSU72 protein or a polynucleotide encoding the same
#12COMPLEX FOR INTRACELLULAR DELIVERY OF MOLECULES
#13Neoantigen peptide mimics
#14TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS
#15Recombinant Bacteria And Uses Thereof
#16Antibodies for binding pathologic forms of calcineurin
#17Method for inhibiting STAT3 activity comprising administering Ssu72
#18Drug-Resistant Immune Cells and Methods of Use Thereof
#19YEAST OVER-EXPRESSING PROTEIN PHOSPHATASES ASSOCIATED WITH THE HOG PATHWAY
#20Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#21Drug Delivery Enhancement Agents
#22Peptides and method for treatment of cardiac arrest
#23Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders
#24THERAPY AND DIAGNOSIS OF DISEASE CHARACTERIZED BY ALTERATIONS IN THE DNA DAMAGE RESPONSE
#25COMPOSITIONS AND METHODS FOR MODULATING PPP2R1A
#26Hypersensitive ABA receptors having modified PP2C-binding interfaces
#27Targeted sensitization of non-del(5q) malignant cells
#28Use of recombinant human calcineurin B subunit
#29Peptides and method for treatment of cardiac arrest
#30Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#31Method of preventing rheumatoid arthritis comprising administering polynucleotide encoding SSU72
#32PRO-APOPTOTIC SET AND PP2A PEPTIDES
#33THERAPEUTIC INTERVENTION GUIDANCE SYSTEM FOR ATOPIC ECZEMA AND A METHOD OF PROVIDING THERAPEUTIC INTERVENTION GUIDANCE
#34SMALL MOLECULE ANTAGONISTS OF DUSP5 AND METHODS OF USE
#35Gene for increasing the production of plant biomass and/or seeds and method for use thereof
#36GENE FOR INCREASING THE PRODUCTION OF PLANT BIOMASS AND/OR SEEDS AND METHOD FOR USE THEREOF
#37GENE FOR INCREASING THE PRODUCTION OF PLANT BIOMASS AND/OR SEEDS AND METHOD FOR USE THEREOF
#38Drug delivery enhancement agents
#39Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders
#40Method for treating pain and method for screening pharmaceutical compositions having an anti-pain effect
#41Nanocomplex containing amphipathic peptide useful for efficient transfection of biomolecules
#42Targeted sensitization of non-del(5q) malignant cells
#43Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#44Gene for increasing the production of plant biomass and/or seeds and method for use thereof
#45Catalytic Tagging System to Study Macro-Molecular Interactions Using Engineered Ubiquitin Ligase and Ubiquitin-Like Proteins to Facilitate Substrate Identification
#46INCREASED PRODUCTION OF SECRETED PROTEINS BY RECOMBINANT EUKARYOTIC CELLS
#47Constitutively active PYR/PYL receptor proteins for improving plant stress tolerance
#48Control of plant stress tolerance, water use efficiency and gene expression using novel ABA receptor synthetic agonists
#49Method for incorporation of recombinant DNA
#50DETECTION OF IMMUNE MODULATION RESULTING FROM REDUCED PROTEIN PHOSPHATASE 2A ACTIVITY
#51COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES
#52GENE FOR INCREASING THE PRODUCTION OF PLANT BIOMASS AND/OR SEEDS AND METHOD FOR USE THEREOF
#53Increased production of secreted proteins by recombinant eukaryotic cells
#54Control of plant stress tolerance, water use efficiency and gene expression using novel ABA receptor proteins and synthetic agonists
#55STRUCTURE OF A PROTEIN PHOSPHATASE 2A HOLOENZYME: INSIGHTS INTO TAU DEPHOSPHORYLATION
#56Methods of Using the Calcineurin A Variant CnA-beta 1
#57CANCER TREATMENT BY METABOLIC MODULATIONS
#58DSP-10 DUAL-SPECIFICITY PHOSPHATASE
#59Methods of identifying an agent capable of interfering with Rad9 dephosphorylation
#60Use of pp2a phosphatase modulators in the treatment of mental disorders
#61Method of converting the state of proteins
#62DSP-10 dual-specificity phosphatase
#63Cancer treatment by metabolic modulations
#64Antisense modulation of dual specific phosphatase 5 expression
#65DSP-5 dual-specificity phosphatase
#66Methods and compositions for enhancing neuron growth and survival